U.S. flag

An official website of the United States government

NM_024675.4(PALB2):c.1273G>A (p.Val425Met) AND not provided

Germline classification:
Conflicting interpretations of pathogenicity (2 submissions)
Last evaluated:
Aug 16, 2023
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000236471.21

Allele description [Variation Report for NM_024675.4(PALB2):c.1273G>A (p.Val425Met)]

NM_024675.4(PALB2):c.1273G>A (p.Val425Met)

Gene:
PALB2:partner and localizer of BRCA2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16p12.2
Genomic location:
Preferred name:
NM_024675.4(PALB2):c.1273G>A (p.Val425Met)
HGVS:
  • NC_000016.10:g.23635273C>T
  • NG_007406.1:g.11085G>A
  • NM_024675.4:c.1273G>AMANE SELECT
  • NP_078951.2:p.Val425Met
  • NP_078951.2:p.Val425Met
  • LRG_308t1:c.1273G>A
  • LRG_308:g.11085G>A
  • LRG_308p1:p.Val425Met
  • NC_000016.9:g.23646594C>T
  • NM_024675.3:c.1273G>A
  • Q86YC2:p.Val425Met
  • p.V425M
Protein change:
V425M
Links:
UniProtKB: Q86YC2#VAR_066366; dbSNP: rs576081828
NCBI 1000 Genomes Browser:
rs576081828
Molecular consequence:
  • NM_024675.4:c.1273G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000292646GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Likely benign
(Jan 15, 2021)
germlineclinical testing

Citation Link,

SCV001134534Quest Diagnostics Nichols Institute San Juan Capistrano
criteria provided, single submitter

(Quest Diagnostics criteria)
Uncertain significance
(Aug 16, 2023)
unknownclinical testing

PubMed (17)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

PALB2 chromatin recruitment restores homologous recombination in BRCA1-deficient cells depleted of 53BP1.

Belotserkovskaya R, Raga Gil E, Lawrence N, Butler R, Clifford G, Wilson MD, Jackson SP.

Nat Commun. 2020 Feb 10;11(1):819. doi: 10.1038/s41467-020-14563-y.

PubMed [citation]
PMID:
32041954
PMCID:
PMC7010753

Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.

Yurgelun MB, Kulke MH, Fuchs CS, Allen BA, Uno H, Hornick JL, Ukaegbu CI, Brais LK, McNamara PG, Mayer RJ, Schrag D, Meyerhardt JA, Ng K, Kidd J, Singh N, Hartman AR, Wenstrup RJ, Syngal S.

J Clin Oncol. 2017 Apr 1;35(10):1086-1095. doi: 10.1200/JCO.2016.71.0012. Epub 2017 Jan 30.

PubMed [citation]
PMID:
28135145
PMCID:
PMC5455355
See all PubMed Citations (17)

Details of each submission

From GeneDx, SCV000292646.12

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant is associated with the following publications: (PMID: 20722467, 28825143, 18446436, 21618343, 25980754, 29387807, 26489409)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Quest Diagnostics Nichols Institute San Juan Capistrano, SCV001134534.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (17)

Description

In the published literature, this variant has been reported in individuals affected with breast cancer (PMIDs: 18446436 (2009), 20722467 (2010), 21618343 (2011), 26489409 (2015), 28825143 (2017), 30287823 (2018)), a Lynch syndrome-associated cancer and/or colorectal polyps (PMID: 25980754 (2015)), colorectal cancer (PMIDs: 28135145 (2017), 33309985 (2020)), prostate cancer (PMID: 31214711 (2020)), as well as in unaffected individuals (PMIDs: 20722467 (2010), 30287823 (2018), 33309985 (2020)). One functional study reported that this variant does not interfere with histone binding as a part of DNA repair (PMID: 32041954 (2020)), however further research is needed. The frequency of this variant in the general population, 0.0015 (21/14420 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded predictions that this variant is benign. Based on the available information, we are unable to determine the clinical significance of this variant.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 26, 2024